Bupranolol

Bupranolol

SCHEMBL6508337

Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1.Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.63
MEN1 O00255 1/20 0.63
HTT P42858 1/20 0.63
KMT2A Q03164 1/20 0.63
NPSR1 Q6W5P4 2/20 0.56
ACHE P22303 1/20 0.56
MAPT P10636 2/20 0.56
GLA P06280 1/20 0.56
SLC2A1 P11166 1/20 0.54
CYP2D6 P10635 2/20 0.52
ADRB2 P07550 3/20 0.52
ADRB1 P08588 2/20 0.52
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
ADRA2B P18089 1/20 0.51
MAOA P21397 1/20 0.51
HTR2B P41595 1/20 0.51
ADRB3 P13945 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bupranolol SCHEMBL29518497 1.00 L3MBTL1 (0.63) L3MBTL1MEN1HTTKMT2ANPSR1
Bupranolol SCHEMBL34061 1.00 L3MBTL1 (0.63) L3MBTL1MEN1HTTKMT2ANPSR1
Bupranolol SCHEMBL2497819 1.00 L3MBTL1 (0.63) L3MBTL1MEN1HTTKMT2ANPSR1
Bupranolol SCHEMBL123717 1.00 L3MBTL1 (0.63) L3MBTL1MEN1HTTKMT2ANPSR1
Bupranolol SCHEMBL348360 0.99 L3MBTL1 (0.65) L3MBTL1MEN1HTTKMT2ANPSR1
Bupranolol SCHEMBL348362 0.99 L3MBTL1 (0.65) L3MBTL1MEN1HTTKMT2ANPSR1
SCHEMBL348361 0.92 L3MBTL1 (0.63) L3MBTL1MEN1HTTKMT2ANPSR1
Bupranolol SCHEMBL8908385 0.90 L3MBTL1 (0.53) L3MBTL1MEN1HTTKMT2ANPSR1
Bupranolol SCHEMBL19816741 0.89 LMNA (0.55) L3MBTL1MEN1HTTKMT2ANPSR1
SCHEMBL12215557 0.88 SLC2A1 (0.57) L3MBTL1MEN1HTTKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005099699-A1 COMBINATION OF (S)-AMLODIPINE AND A BETA-BLOCKER, AND METHODS FOR REDUCING HYPERTENSION SEPRACOR INC. (US) 2005-10-27 WO disclosed